Shionogi

Shionogi & Co., Ltd. (Japanese: シオノギ株式会社) is a Japanese pharmaceutical company best known for developing Crestor. Medicines produced by Shionogi are often used to treat infections, pain, cardiovascular disease, and central nervous system disorders.

History[edit | edit source]

Shionogi was founded in Osaka in 1878 by Gisaburo Shiono. The company started as a small family business selling traditional herbal medicine. Over the years, Shionogi has grown into a major pharmaceutical company with a strong presence in the Japanese market and a growing influence globally.

Research and Development[edit | edit source]

Shionogi has a strong commitment to research and development, with a focus on creating innovative medicines that address unmet medical needs. The company's research efforts are primarily focused on the areas of infectious disease, pain, cardiovascular disease, and central nervous system disorders.

Products[edit | edit source]

Shionogi's product portfolio includes a wide range of medicines, including Crestor for cholesterol management, Dificid for the treatment of Clostridium difficile infection, and Osphena for the treatment of dyspareunia.

Global Presence[edit | edit source]

Shionogi has a global presence with offices and research facilities in several countries, including the United States, United Kingdom, and China. The company's products are sold in more than 70 countries worldwide.